维普中文期刊产品整合服务
18篇 您的检索式:作者名="TOMASOV P"
    题名 作者 年代 出处 被引量
1Long-term effects of varying al- cohol dosing in percutaneous septal ablation for obstructive hyper- trophic cardiomyopathy: a randomized study with a follow-up up to 11 years显示文摘Veselka J Tomasov P Zemanek D 2011Can J Cardiol2011,27,6:1
2Mid- term outcomes of alcohol septal ablation for obstruc- tive hypertrophic cardiomyopathy in patients with sig- moid versus neutral ventricular septum 显示文摘VESELKA J TOMASOV P ZEM? NEK D 2012J Invasive Cardiol2012,24,:1
3Complications of low- dose, echo-guided alcohol septal ablation 显示文摘Veselka J Zemanek D Tomasov P 2010Catheter Cardiovase Interv2010,75,4:1
4Alcohol septal ablation for obstructive hypertrophie cardiomyopathy: ultra-low dose of alcohol (1 mL) is still effective 显示文摘Veselka J Zemanek D Tomasov P 2009Heart Vessels2009,24,1:1
5Complications of low-dose, echo-guided alcohol septal ablation显示文摘Veselka J Zemanek D Tomasov P 2010Catheter Cardiovasc Interv2010,75,4:1
6Dual-source CT angiography for detection and quantification of in-stent restenosis in the left main cor- onary artery : compariron with intracoronary ultrasound and coronary angi- ography显示文摘Veselka J Cadova P Tomasov P 2011J Invasive Cardiol2011,23,11:1
7Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy显示文摘Posch M G Thiemann L Tomasov P 0,,05:1
8Alcohol septal ablation for obstructive hypertrophic cardiomyopathy:ultra-low dose of alcohol (1 ml) is still effective显示文摘Veselka J Zemanek D Tomasov P 2009Heart Vessels2009,24,1:1
9Complications of low-dose, echo guided alcohol septal ablation显示文摘VESELKA J ZEMANEK D TOMASOV P 2010Catheter Cardiovasc Interv2010,75,:1
10Long- term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomy- opathy: a randomized study with a follow-up up to 11 years显示文摘VESELKA J TOMASOV P ZEMANEK D 2011CanJ Cardiol2011,27,:1
11Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population显示文摘Veselka J Krejci J Tomasov P 2014Eur Heart J2014,24,:1
12Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum显示文摘VeselkaJ Tomasov p Zemanek D 2012J Invasive Cardiol2012,24,:1
13Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alco- hol (1 ml) is still effective显示文摘Veselka J ZemOnek D Tomasov P 2009Heart Vessels2009,24,1:1
14Complications of lowdose,echo-guided alcohol septal ablation显示文摘Veselka J Zemanek D Tomasov P 0,,04:1
15Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hyper- trophic cardiomyopathy: a randomized study with a follow-up up to 11 years显示文摘Veselka J Tomasov P Zemanek D 2011Can J Cardiol2011,27,6:1
16Mid-term outcomes of alcoholseptal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum显示文摘Veselka J Tomasov P Zemanek D 2012J lnva- sive Cardiol2012,24,12:1
17Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population 显示文摘Veselka J Krejci J Tomasov P 2014Eur Heart J2014,35,30:1
18The role of tisue factor in thrombosis and hemostasis 显示文摘Mal MA Tomasov P Hojek P 2007Physiol Res2007,56,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费